SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-20-327681
Filing Date
2020-12-28
Accepted
2020-12-28 16:30:52
Documents
2
Group Members
GUY LEVYSOLEUS BA SPV, LLCSOLEUS CAPITAL GROUP, LLCSOLEUS CAPITAL MASTER FUND, L.P.SOLEUS CAPITAL, LLCSOLEUS PE GP I, LLCSOLEUS PRIVATE EQUITY GP I, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d47810dsc13d.htm SC 13D 155454
2 EX-99.1 d47810dex991.htm EX-99.1 13189
  Complete submission text file 0001193125-20-327681.txt   170483
Mailing Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830
Business Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830 475-208-3178
Soleus Private Equity Fund I, L.P. (Filed by) CIK: 0001752427 (see all company filings)

IRS No.: 824521410 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Subject) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91930 | Film No.: 201418690
SIC: 2836 Biological Products, (No Diagnostic Substances)